At Austin Urology Institute, we’re proud to announce that we’ve been selected to participate in an exciting new clinical study for kidney stone patients. This study focuses on a promising treatment that could reduce the risk of recurrent kidney stones, and we’re inviting our patients to see if they might qualify. Not only is this an opportunity to access cutting-edge care, but participants are also compensated for their time and travel.
What’s the Study About?
The study, officially known as LLX-002, is exploring the safety and effectiveness of a new investigational drug called LLX-424. This medication targets kidney stone recurrence by lowering levels of urinary oxalate, a key contributor to stone formation. The study is specifically for patients who have had calcium oxalate kidney stones in the past.
How Does LLX-424 Work?
Here’s the science behind the treatment: LLX-424 is designed to block the production of oxalate in the liver, reducing the amount of oxalate in the urine. Lower urinary oxalate levels can mean a lower chance of kidney stones forming in the future. Early studies have shown promising results, with patients experiencing decreased oxalate levels and minimal side effects.
Why Participate?
Participating in a clinical study isn’t just about helping yourself; it’s about contributing to the future of medical care. Here are some great reasons to consider joining:
- Access to Cutting-Edge Treatment: Be among the first to benefit from this innovative medication.
- Compensation: Patients who complete the study can receive up to $4,900, with travel costs covered if necessary.
- Comprehensive Care: As part of the study, you’ll receive close monitoring from a dedicated medical team.
- Helping Others: Your participation will contribute to vital research that could help kidney stone patients worldwide.
What Does the Study Involve?
The study lasts approximately 106 days and includes:
– Regular outpatient visits
– Four overnight stays at the research clinic
– Blood and urine testing
– Taking the study drug once a day
Our team will walk you through every step of the process to make sure you feel comfortable and supported.
Who’s Eligible?
To qualify for the study, participants must:
– Be between the ages of 18 and 75
– Have a history of kidney stones (specifically calcium oxalate stones)
– Meet certain health criteria, including adequate kidney function
Our team will review your medical history and perform a few tests to determine if you’re eligible.
Is This Right for You?
While this study is a fantastic opportunity, it’s important to note that it’s not for everyone. If you’re not sure whether you’re a good candidate, reach out to us. We’ll help you evaluate your options and guide you toward the best path forward. At Austin Urology Institute, we’re proud to offer a variety of treatments for kidney stones, so we’ll always find a solution that works for you.
Ready to Learn More?
If you’re interested in participating in this groundbreaking study, contact us today! Our team will help determine if you’re eligible and answer any questions you might have. Call us or visit our website to get started.
Don’t miss this opportunity to take part in cutting-edge research and make a difference in the future of kidney stone care. We’re here to help you every step of the way.
Virtual Visits Available
We offer both in-clinic and remote telemedicine consultations in Texas.
Our top-rated practitioners are available for remote telemedicine consultations across the state of Texas.